GLT-1 dysregulation occurs in various neurological diseases including Huntington’s disease (HD), Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and epilepsy. The gene discussed is SLC1A2; the disease is early-onset autosomal dominant Alzheimer disease.